• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center



DRP Award Recipients

Development Research Program Award Recipients
Principal Investigator Institution Project Name
2012-2013 RECIPIENTS (YEAR 9)    
McClatchey, Andrea MGH Molecular Relationship between NF2 and VHL in Renal Cancer
Panka, D. BIDMC Reversal of Sunitinib Induced Modifications of the Tumor ECM and MDSC Recruitment by HDM2 Antagonism
Sabbisetti, V BWH KIM 1 as a Biomarker and Therapeutic Target of RCC
Henske, Elizabeth BWH The Molecular Pathogenesis of Chromophobe RCC
2011-2012 RECIPIENTS (YEAR 8)    
Choueiri, Toni DFCI The Role of Genetic Polymorphisms and Recurrence in Renal Call Carcinoma
Zhu, Shudong BIDMC Role of the Unfolded Protein Response (UPR) in the Development or Resistance to Antiangiogenic Agents in Renal Cell Carcinoma
Henske, Elizabeth BWH PKP4 and Cell Adhesion in the Pathogenesis of Chromophobe RCC
Wagner, Andrew BIDMC Evaluation Compartive Effectivenes of Open and Minimally Invasive Kidney Surgery: Patient-Reported Quality of Life Outcomes and Cost Effectiveness
2010-2011 RECIPIENTS (YEAR 7)    
Iliopoulos, O. MGH Preclinical Validation of HIF2a Inhibitors
Panka, D. BIDMC Synergy Between the HDM2/HDMX Antagonist AT-210 and the VEGFR2 Antagonist Sunitinib in the Treatment of Advanced Renal Cell Carcinoma
Cai, G. DFCI Immunotherapy of RENCA tumor by boosting host anti-tumor immune responses through dual blockade of CTLA4 and PD-1
Libermann, T and Kung, A. BIDMC DFCI Validation of Novel Strategies for Renal Cell Cancer
Chang, S. BWH Cost Effectiveness Analysis of Routine Percutaneous Renal Biopsy in the Management of Small Renal Masses
2009-2010 RECIPIENTS (YEAR 6)    
Iliopoulos, O. MGH Glycoproteomic analysis of Renal Cell Carcinoma biomarkers
Rosenblatt, J. BIDMC PD-1 Blockade in Conjunction with DC/RCC Fusion Cell Vaccination: Pre-Clinical Studies in Preparation for Clinical Trial
Signoretti, S and Choueiri, T. BWH DFCI Clinical, Histological and Molecular Determinants of Bilateral RCC